Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Oklahoma for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Oklahoma only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Oklahoma (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Amy Shultz (NPI 1063462430)

Field	Value
Entity Type	Individual
Organization	Amy Shultz
Address	1515 N Brookwood Dr
City	Duncan
State	OK
ZIP	73533
Taxonomy	Rheumatology Physician
NPI Enumerated	May 10, 2006

Payer Source	Total Paid
Medicare	$1.7M
Medicaid	$0

Key Findings

This provider’s billed Medicare footprint is concentrated but meaningful in scale: lifetime Medicare revenue is $1.7M while Medicaid revenue is none (no Medicaid billing on file), making AMY SHULTZ effectively a Medicare-focused practice. The taxonomy on record is Rheumatology Physician and the NPI was enumerated 2006-05-10 (~20 years ago), indicating long-standing Medicare participation.

Revenue concentration in Medicare is high: the precomputed top 3 Medicare codes account for 75.2% of the provider’s total Medicare revenue, driven primarily by J0129, J0897, and J1602. Those codes individually represent $587.4K (35.1%), $413.6K (24.7%), and $256.5K (15.3%) of Medicare revenue respectively, showing dependence on a small set of high-revenue drug administrations.

The code mix indicates an infusion- and injection-centered rheumatology practice that administers biologic and bone-related specialty agents: J0129 (abatacept), J0897 (denosumab), J1602 (golimumab IV) and J3111 (romosozumab) together reflect ongoing in-office drug administration rather than only cognitive outpatient care. The presence of infusion/chemotherapy administration codes such as 96413 and add-on 96415 further supports that the practice delivers parenteral specialty therapies and monitored infusions on-site.

Competitive standing varies by drug code: for J0897 the provider ranks #205 of 10057 nationally at the 98th percentile and is notably above typical national volume for that drug, marking national-level prominence for denosumab administration. By contrast, J0129 (rank #183 of 1221, 85th percentile) and J1602 (rank #209 of 1041, 80th percentile) are described as typical or unremarkable volumes, indicating the practice is a strong national outlier for some but not all of its top drug therapies.

Office evaluation-and-management work is also a significant component of the practice: 99214 (855 claims, $67.5K revenue) and 99215 (372 claims, $43.9K revenue) both rank in the 97th percentile and are characterized as notably above typical national volume. These high-percentile E/M volumes suggest a steady stream of follow-up care and complex patient management typical of rheumatology longitudinal care.

Several procedural and injection codes are extreme or notable outliers in national rank, pointing to high procedural throughput: 96372 (817 claims) ranks in the 99th percentile and is labeled an extreme outlier, and J1040 (579 claims) ranks in the 98th percentile and is also an extreme outlier. High ranks for 20610 (408 claims, 95th percentile) and J3301 (2K claims, 96th percentile) further indicate frequent joint procedures and corticosteroid injections as operationally important services.

From a payer- and business-risk perspective, the practice’s revenue profile is concentrated in a few biologic and specialty drug administrations (top 3 codes = 75.2% of Medicare revenue), which creates sensitivity to changes in drug pricing, Medicare coverage policy, or site-of-care reimbursement. The lack of any Medicaid billing on file also means limited diversification across public payers, so changes in Medicare policy would have outsized impact on overall revenue.

Given the NPI was enumerated on 2006-05-10 (~20 years ago), this provider has sustained presence in the market and appears to have built an infusion-heavy rheumatology practice over time; operational patterns (high E/M, frequent injections, and prominent denosumab volume) are consistent with a steady outpatient specialty clinic focused on biologic therapies and procedural injections.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

24 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	17,280	$30	$587.4K
J0897	Injection, denosumab, 1 mg	22,980	$20	$413.6K
J1602	Injection, golimumab, 1 mg, for intravenous use	25,650	$10	$256.5K
J3111	Injection, romosozumab-aqqg, 1 mg	24,990	$10	$199.9K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	860	$80	$67.5K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	370	$120	$43.9K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	350	$90	$30.6K
20610	In this procedure, the provider inserts a needle through the skin of a patient and into a major joint or bursa and then uses the syringe attachment to the needle to remove fluid or he may inject a…	410	$50	$22K
96365	The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.	250	$50	$11.4K
J3304	Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg	800	$10	$10.4K

Showing 1–10 of 24

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 24 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Oklahoma Distribution

Amy Shultz — 6 of 23 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Oklahoma

Full comparison — all codes billed, vs. state median

24 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0129	6	10	16,680	$30	$661.9K
J1602	8	20	25,400	$10	$412.3K
J3111	5	20	22,470	$10	$216.7K
J0897	3	70	2,130	$20	$91.2K
J3304	37	40	1,820	$10	$34.1K
96413	18	60	210	$90	$26.4K
99214	281	5,560	130	$70	$18.4K
99215	33	1,310	40	$110	$8.2K
96365	15	80	60	$40	$6.9K
99204	2,034	2,790	40	$100	$5.8K

Showing 1–10 of 24

Nearby Providers

Other providers in the same ZIP code as Amy Shultz, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Duncan Regional Hospital, Inc.	OK	Rural Acute Care Hospital	$0	$17.8M
Association South Central Oklahoma Governments	OK	Case Management Agency	$0	$5.9M
Duncan Regional Hospital, Inc.	OK	Rural Health Clinic/Center	$0	$4.7M
Duncan Regional Hospital, Inc	OK	Rural Health Clinic/Center	$0	$4.2M
Urgent Med LLC	OK	Urgent Care Clinic/Center	$0	$3.9M
Duncan Regional Hospital, Inc	OK	Rural Health Clinic/Center	$0	$3.6M
Chisholm Trail Retirement Community	OK	Assisted Living Facility	$0	$3.5M
Duncan Regional Hospital, Inc.	OK	Rural Health Clinic/Center	$0	$3.4M
Sooner Mobile X-ray, Inc.	OK	Portable X-ray and/or Other Portable Diagnostic Imaging Supplier	$1.1M	$1.4M
Duncan Regional Hospital, Inc.	OK	Rural Health Clinic/Center	$0	$2.3M

Amy Shultz — Billing Profile & Reimbursement Data

Sign up for Amy Shultz — Billing Profile & Reimbursement Data policy alerts

Amy Shultz — Billing Profile & Reimbursement Data

Sign up for Amy Shultz — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Nearby Providers

Frequently Asked Questions

References